The pesticide chlorpyrifos increases the risk of Parkinson's disease.

Saved in:
Bibliographic Details
Title: The pesticide chlorpyrifos increases the risk of Parkinson's disease.
Authors: Hasan KMM; Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095, USA., Barnhill LM; Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095, USA., Paul KC; Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095, USA., Peng C; Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095, USA., Zeiger W; Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095, USA., Ritz B; Department of Epidemiology, University of California-Los Angeles, Los Angeles, CA, 90095, USA.; Environmental and Molecular Toxicology Interdepartmental Program, University of California Los Angeles, Los Angeles, CA, 90095, USA., Arellano M; Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095, USA.; Environmental and Molecular Toxicology Interdepartmental Program, University of California Los Angeles, Los Angeles, CA, 90095, USA., Ajnassian M; Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095, USA., Zhang S; Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095, USA., Theint AT; Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095, USA., Elezi G; Pasarow Mass Spectrometry Laboratory, The Jane and Terry Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA., Weinberger H; Pasarow Mass Spectrometry Laboratory, The Jane and Terry Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA., Whitelegge JP; Pasarow Mass Spectrometry Laboratory, The Jane and Terry Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA., Bai Q; Department of Neurology and Pittsburgh Institute for Neurodegenerative Disease, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213- 3301, USA., Li S; Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095, USA., Burton EA; Department of Neurology and Pittsburgh Institute for Neurodegenerative Disease, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213- 3301, USA.; Geriatric Research, Education, and Clinical Center, Pittsburgh VA Healthcare System, Pittsburgh, PA, 15240, USA., Bronstein JM; Department of Neurology, David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095, USA. jbronste@mednet.ucla.edu.; Environmental and Molecular Toxicology Interdepartmental Program, University of California Los Angeles, Los Angeles, CA, 90095, USA. jbronste@mednet.ucla.edu.
Source: Molecular neurodegeneration [Mol Neurodegener] 2025 Dec 11; Vol. 21 (1), pp. 3. Date of Electronic Publication: 2025 Dec 11.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101266600 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1326 (Electronic) Linking ISSN: 17501326 NLM ISO Abbreviation: Mol Neurodegener Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1750-1326
DOI:10.1186/s13024-025-00915-z